drugset / Trial / NCT00504712

Testosterone for Peripheral Vascular Disease

NCT00504712

Phase 4 Completed 24 enrolled Barnsley Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

There is increasing evidence of the linkage of type 2 diabetes with low testosterone levels in men.

Timeline

Start
2006-02
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 200 mg Intramuscular